BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:JNJ-98768111 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of JNJ-98768111\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07746713-11221@assetmemo.bio
DTSTAMP:20261121T005738Z
DTSTART;VALUE=DATE:20290316
DTEND;VALUE=DATE:20290317
SUMMARY:JNJ-98768111: Phase 1 readout est. (NCT07746713)
DESCRIPTION:JNJ-98768111\, phase 1\, Prostate Cancer.\nStudy: A Study of JN
 J-98768111 in Participants With Advanced Prostate Cancer\nEstimated primar
 y completion: 16 March 2029. This is a ClinicalTrials.gov estimate\, not a
  confirmed readout date\, and it can move.\nDrug page: https://assetmemo.b
 io/drug/jnj-98768111#upcoming-events\nRegistry record: https://clinicaltri
 als.gov/study/NCT07746713
URL:https://assetmemo.bio/drug/jnj-98768111#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
